South Korea approves Moderna’s COVID-19 vaccine

By: |
May 21, 2021 10:32 AM

The green light comes after two of three expert panels recommended approval be granted for the two-dose vaccine based on safety and efficacy in late-stage trials in the United States.

More than 1.80 crore doses are still available with the states and UTs and another 48 lakh are in the pipeline to be distributed in the next three days, he added.More than 1.80 crore doses are still available with the states and UTs and another 48 lakh are in the pipeline to be distributed in the next three days, he added.

South Korea on Friday approved Moderna Inc’s COVID-19 vaccine, as the country attempts to speed up its inoculation efforts, drug safety minister Kim Gang-lip told a news conference.

The green light comes after two of three expert panels recommended approval be granted for the two-dose vaccine based on safety and efficacy in late-stage trials in the United States.

Moderna is the fourth COVID-19 vaccine to be approved in South Korea, following doses developed by AstraZeneca Plc , Pfizer Inc and Johnson & Johnson, said Kim.

Moderna has a deal with South Korea to supply 40 million doses of its vaccine, although the shipment timeline is yet to be announced.

South Korean drugmaker GC Pharma is in charge of the import and local distribution of the Moderna vaccine, while there were media reports about a plan by Samsung BioLogics Co Ltd to produce the shots locally.

Seoul has ordered up to 192 million doses of coronavirus vaccines, including those made by AstraZeneca, Pfizer, Novavax and Johnson & Johnson.

South Korea’s vaccination campaign has been hampered by global shortages and shipment delays. It has provided doses to just over 7% of its 52 million residents so far, as it aims to inoculate at least 13 million by June and reach herd immunity by November.

The Korea Disease Control and Prevention Agency reported 561 new confirmed cases of the coronavirus on Thursday, bringing the total tally to 134,678 infections, with 1,922 deaths.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Tamil Nadu lockdown update: Bus, Metro Rail services to resume in Chennai; TN govt eases more curbs
2Delhi records 124 new COVID-19 cases, lowest since February 16; positivity rate 0.17 pc
3Haryana extends lockdown till June 28, announces more relaxations